ID   SHIN-3/PTEN
AC   CVCL_W128
DR   cancercelllines; CVCL_W128
DR   Wikidata; Q54953344
RX   PubMed=18347155;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9588; PTEN.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A670 ! SHIN-3
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
RX   PubMed=18347155; DOI=10.1158/1535-7163.MCT-06-0724;
RA   Takei Y., Saga Y., Mizukami H., Takayama T., Ohwada M., Ozawa K.,
RA   Suzuki M.;
RT   "Overexpression of PTEN in ovarian cancer cells suppresses i.p.
RT   dissemination and extends survival in mice.";
RL   Mol. Cancer Ther. 7:704-711(2008).
//